The Inhibitory Effects of Anti-ERC/Mesothelin Antibody 22A31 on Colorectal Adenocarcinoma Cells, within a Mouse Xenograft Model

SIMPLE SUMMARY: The expression of Renal Carcinoma (ERC)/mesothelin is overexpressed in malignancies such as mesothelioma, pancreatic cancer, and ovarian cancer, and molecular-targeted therapies against ERC/mesothelin have been developed to treat them. Recently, it was revealed that ERC/mesothelin is...

Descripción completa

Detalles Bibliográficos
Autores principales: Taniguchi, Gentaro, Kajino, Kazunori, Momose, Shuji, Saeki, Harumi, Yue, Liang, Ohtsuji, Naomi, Abe, Masaaki, Shibuya, Tomoyoshi, Orimo, Akira, Nagahara, Akihito, Watanabe, Sumio, Hino, Okio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101225/
https://www.ncbi.nlm.nih.gov/pubmed/35565327
http://dx.doi.org/10.3390/cancers14092198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9101225/
https://www.ncbi.nlm.nih.gov/pubmed/35565327
http://dx.doi.org/10.3390/cancers14092198

Ejemplares similares